12 de June de 2019

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:

(i) the cultivation of the cannabis spp. for medical and scientific purposes; and

(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.

For further information, click below to access our full newsletter.

Last related news

24 de April de 2025

During software compliance audits, it is not uncommon for companies to claim that pirated programs were installed by external contractors or IT … Third Parties and Software Piracy: Companies Remain Legally Responsible

Kasznar Leonardos

16 de April de 2025

The Public Consultation (CP) No. 1.316/2025, which aims to initiate the review process of Collegiate Board Resolution (RDC) No. 327/2019 from the … Medicinal Cannabis Review: Public Consultation 1.316/2025 open

15 de April de 2025

The Federal Senate has approved a bill (PLS nº 404/2018) that extends the protection period for new plant varieties (cultivars). According to … Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required